Clinical Trial Update: Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating LILRA6 CAR-T therapy for relapsed or refractory acute myeloid leukemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• LILRA6 CAR-T

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Refractory Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia | Phase 1 | Status: RECRUITING